Advanced search
Publication Cover
Hematology Volume 16, 2011 - Issue 5
Submit an article Journal homepage
647
Views
17
CrossRef citations to date
0
Altmetric
OriginalArticle

Reduced corticosteroid use in adult patients with primary immune thrombocytopenia receiving romiplostim

Marc MichelService de Médecine InterneCHU Henri Mondor AP-HP, Université Paris, Créteil, FranceCorrespondence[email protected]
,
Peter A W te BoekhorstDepartment of HematologyErasmus Medical Center, Rotterdam, The Netherlands
,
Ann JanssensDepartment of HematologyUniversity Hospitals Leuven, Belgium
,
Ingrid Pabinger-FaschingDepartment of Internal MedicineMedical University of Vienna, Austria
,
Miguel A SanzDepartment of HaematologyUniversity Hospital La Fe, Valencia, Spain
,
Kun NieAmgen (Europe) GmbHZug, Switzerland
&
Georg KreuzbauerAmgen Inc.Thousand Oaks, CA, USA
 show all
Pages 274-277 | Published online: 12 Nov 2013

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Lorenzo Cirasino, Anna M. Robino, GianMarco Podda, Emmanuel Andrès, Jenny M. Despotovic, Mohsen Elalfy, Andreas Holbro, Tadakazu Kondo, Michele P. Lambert, Sandra R. Loggetto, Keith R. McCrae, Jong Wook Lee & Marco Cattaneo. (2020) Report of a ‘consensus’ on the lines of therapy for primary immune thrombocytopenia in adults, promoted by the Italian Gruppo di Studio delle Piastrine. Platelets 31:4, pages 461-473.
Read now
Sarah Chalmers & Michael D Tarantino. (2015) Romiplostim as a treatment for immune thrombocytopenia: a review. Journal of Blood Medicine 6, pages 37-44.
Read now
Ann Janssens. (2012) Romiplostim for the treatment of primary immune thrombocytopenia. Expert Review of Hematology 5:2, pages 133-144.
Read now

Articles from other publishers (14)

Dražen Pulanić, Angelika Bátorová, Imre Bodó, Libor Červinek, Ioana Ionita, Toshko Lissitchkov, Anahit Melikyan & Maria Podolak-Dawidziak. (2023) Use of thrombopoietin receptor agonists in adults with immune thrombocytopenia: a systematic review and Central European expert consensus. Annals of Hematology 102:4, pages 715-727.
Crossref
David J. Kuter, Michael D. Tarantino & Tatiana Lawrence. (2021) Clinical overview and practical considerations for optimizing romiplostim therapy in patients with immune thrombocytopenia. Blood Reviews 49, pages 100811.
Crossref
Adam Cuker & Howard A. Liebman. (2021) Corticosteroid overuse in adults with immune thrombocytopenia: Cause for concern. Research and Practice in Thrombosis and Haemostasis 5:6, pages e12592.
Crossref
Quentin A. Hill, John D. Grainger, Jecko Thachil, Drew Provan, Gillian Evans, Mamta Garg, Charlotte Bradbury, Catherine Bagot, John A. Kanis & Juliet E. Compston. (2019) The prevention of glucocorticoid‐induced osteoporosis in patients with immune thrombocytopenia receiving steroids: a British Society for Haematology Good Practice Paper. British Journal of Haematology 185:3, pages 410-417.
Crossref
Ryan K DasGupta, Lauren Levine, Tracy Wiczer & Spero Cataland. (2018) Initial romiplostim dosing and time to platelet response in patients with treatment refractory immune thrombocytopenia. Journal of Oncology Pharmacy Practice 25:3, pages 567-576.
Crossref
Gürkan Bal, Depré Fabian, Dzamashvili Maia, Frauke Ringel & Abdulgabar Salama. (2017) Effect of thrombopoietin receptor agonists on leukocyte and haematopoietic stem and progenitor cells in the peripheral blood of patients with immune thrombocytopenic purpura. Annals of Hematology 96:12, pages 2045-2056.
Crossref
Michael D. Tarantino & Sarah Chalmers. 2017. Platelets in Thrombotic and Non-Thrombotic Disorders. Platelets in Thrombotic and Non-Thrombotic Disorders 1417 1429 .
Francesco Rodeghiero, Roberto Stasi, Aristoteles Giagounidis, Jean-François Viallard, Bertrand Godeau, Ingrid Pabinger, Douglas Cines, Howard Liebman, Xuena Wang & Paul Woodard. (2013) Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials. European Journal of Haematology 91:5, pages 423-436.
Crossref
Dawn Lee, Patrick Thornton, Alexander Hirst, Lucie Kutikova, Robert Deuson & Nic Brereton. (2013) Cost Effectiveness of Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in Ireland. Applied Health Economics and Health Policy 11:5, pages 457-469.
Crossref
Tomonori Nakazato, Chisako Ito, Ai Mihara & Yoshinobu Aisa. (2012) Successful treatment of eltrombopag-resistant refractory immune thrombocytopenia with romiplostim. International Journal of Hematology 97:2, pages 291-293.
Crossref
Deborah Siegal, Mark Crowther & Adam Cuker. (2013) Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia. Seminars in Hematology 50, pages S18-S21.
Crossref
Ivy Altomare, Jeffrey Wasser & Vinod Pullarkat. (2012) Bleeding and mortality outcomes in ITP clinical trials: A review of thrombopoietin mimetics data. American Journal of Hematology 87:10, pages 984-987.
Crossref
Paul A. Basciano & James B. Bussel. (2012) Thrombopoietin-receptor agonists. Current Opinion in Hematology 19:5, pages 392-398.
Crossref
Gillian M. Keating. (2012) Romiplostim. Drugs 72:3, pages 415-435.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.